Page 189 - 2022 Ranger Medic Handbook

SUMATRIPTAN (IMATREX)
Class: Antimigraine
Action: Insert action
Dose: Tabs 25–100mg PO single dose q2hr. Max 300mg/d. SC injection initial 6mg repeated in 1–2 hours if needed.
Max 6mg q24hr. If migraine symptoms return, 50mg PO q2hr, up to 200mg
Indications: Relief of acute migraine headaches
Contraindications: Basilar migraine, cardiovascular disease, concurrent use of ergotamine-containing drugs, hyper-
sensitivity, ischemic heart disease, use within 14 days of MAOIs, within 24 hours of serotonin receptor agonist, preg-
nancy category caution advised during pregnancy and may use while breastfeeding
Adverse/Side-effects: Anxiety, dizziness, drowsiness, fatigue, fever, malaise, sedation, seizures, vertigo, arrhyth-
mias, coronary artery vasospasm, chest tightness, hypertension, palpitations, abnormal vision, nasal irritation, pho-
tophobia, tongue numbness, abdominal discomfort, dysphagia, muscle cramps, myalgia, dermatitis, diaphoresis,
flushing, pallor, or pruritus
Interactions: Antidepressants, sertraline, and MAOIs
Mission Impact: GROUNDING medication for personnel on flight status SECTION 4

TERBINAFINE (LAMISIL)
Class: Antimicrobial – antibiotic; antifungals
Action: Inhibits sterol biosynthesis in fungi; ergosterol, the principal sterol in the fungal cell membrane, becomes
depleted and interferes with cell membrane function, thus producing antifungicidal effect
Dose: For tinea pedis, tinea cruris, and tinea corporis, topically AAA qd–bid × 1–7 weeks; for onychomycosis, 250mg
PO qd × 6 weeks for fingernails and 12 weeks for toenails (monitor baseline LFTs, repeat at least monthly)
Indications: For topical treatment of superficial mycoses such as interdigital tinea pedis, tinea cruris, and tinea cor-
poris due to Epidermophyton floccosum, Trichophyton mentagrophytes, or T. rubrum; for oral treatment of onychomy-
cosis due to tinea unguium
Contraindications: Terbinafine hypersensitivity; pregnancy category B; elevated LFT or known liver disease, hepatitis
or mononucleosis, pregnancy category may use during pregnancy and caution advised while breastfeeding.
Adverse/Side-effects: Pruritus, local burning, dryness, rash, vesiculation, redness, contact dermatitis at application
site; headache; diarrhea, dyspepsia, abdominal pain, neutropenia; taste disturbances
Interactions: May increase theophylline levels; may decrease cyclosporine and rifampin levels

TETRACAINE OPHTH
Class: Local anesthetic
Dose: 1–2gtt 2–3 minutes before procedure. DO NOT DISPENSE TO PATIENT
Indications: As a topical optic anesthetic (may aid in ocular exam to relieve blepharospasm); removal of foreign bodies
Contraindications: Not for prolonged use, pregnancy category may use during pregnancy and while breastfeeding
Adverse/Side-effects: Stinging, conjunctival redness, tearing swelling, sensitivity to light, transient eye pain, hyper-
sensitivity reactions
Mission Impact: GROUNDING medication for personnel on flight status

2022 RANGER MEDIC HANDBOOK 175